Inflammatory Breast Cancer: Pathogenesis, Diagnosis, and Therapeutic Advances

This track will delve into the pathogenesis, diagnosis, and therapeutic advances in inflammatory breast cancer (IBC). Participants will gain insights into the unique characteristics of IBC, including its aggressive nature and distinctive clinical presentation. The discussions will focus on unraveling the underlying molecular mechanisms contributing to IBC development and progression. Diagnostic challenges, such as differentiating IBC from other breast malignancies, will be addressed, emphasizing the importance of accurate and timely diagnosis. Furthermore, cutting-edge therapeutic strategies and emerging treatment modalities specific to IBC will be explored, highlighting the latest advancements and clinical trials that aim to improve outcomes for patients with this challenging form of breast cancer.

  • Pathogenic Mechanisms and Molecular Signatures
  • Diagnostic Challenges and Advances

Related Conference of Inflammatory Breast Cancer: Pathogenesis, Diagnosis, and Therapeutic Advances

December 14-15, 2023

5th International Conference on Oncology and Cancer

Rome, Italy
February 22-23, 2024

14th World Congress on Breast Cancer

Zurich, Switzerland
March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
March 21-22, 2024

8th Global Meeting on Oncology and Radiology

Paris, France
April 18-19, 2024

24th World Congress on Cancer and Diagnostics

Dubai, UAE

Inflammatory Breast Cancer: Pathogenesis, Diagnosis, and Therapeutic Advances Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in